These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25539511)

  • 1. Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia.
    Aguilar DD; Chen L; Lodge DJ
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.
    Aguilar DD; Giuffrida A; Lodge DJ
    J Psychopharmacol; 2016 Feb; 30(2):169-81. PubMed ID: 26510449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of Δ9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model.
    Seillier A; Martinez AA; Giuffrida A
    PLoS One; 2020; 15(3):e0230238. PubMed ID: 32163506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility.
    Aguilar DD; Giuffrida A; Lodge DJ
    Int J Neuropsychopharmacol; 2018 Apr; 21(4):393-403. PubMed ID: 29329382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
    Gomes FV; Guimarães FS; Grace AA
    Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia.
    Lodge DJ; Grace AA
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):69-76. PubMed ID: 21329556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.
    Chen L; Perez SM; Lodge DJ
    Dev Neurobiol; 2014 Sep; 74(9):907-17. PubMed ID: 24554310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia.
    Perez SM; Carreno FR; Frazer A; Lodge DJ
    J Neurosci; 2014 Jul; 34(28):9261-7. PubMed ID: 25009259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amygdala-ventral pallidum pathway decreases dopamine activity after chronic mild stress in rats.
    Chang CH; Grace AA
    Biol Psychiatry; 2014 Aug; 76(3):223-30. PubMed ID: 24209776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fundamental role for hippocampal parvalbumin in the dopamine hyperfunction associated with schizophrenia.
    Boley AM; Perez SM; Lodge DJ
    Schizophr Res; 2014 Aug; 157(1-3):238-43. PubMed ID: 24888524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic phencyclidine treatment induces long-lasting glutamatergic activation of VTA dopamine neurons.
    Uramura K; Maejima Y; Shimomura K; Santoso P; Katsuda S; Kobayashi D; Jodo E; Kodaira M; Otgon-Uul Z; Yang Y; Sakuma K; Takigawa M; Hazama A; Yada T
    Neurosci Lett; 2014 Apr; 564():72-7. PubMed ID: 24525246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergent Inputs from the Hippocampus and Thalamus to the Nucleus Accumbens Regulate Dopamine Neuron Activity.
    Perez SM; Lodge DJ
    J Neurosci; 2018 Dec; 38(50):10607-10618. PubMed ID: 30355626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal Ethanol Exposure Persistently Alters Endocannabinoid Signaling and Endocannabinoid-Mediated Excitatory Synaptic Plasticity in Ventral Tegmental Area Dopamine Neurons.
    Hausknecht K; Shen YL; Wang RX; Haj-Dahmane S; Shen RY
    J Neurosci; 2017 Jun; 37(24):5798-5808. PubMed ID: 28476947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597.
    Matricon J; Seillier A; Giuffrida A
    Neurosci Res; 2016 Sep; 110():49-58. PubMed ID: 27091613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
    Gill KM; Cook JM; Poe MM; Grace AA
    Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
    Castañé A; Santana N; Artigas F
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat.
    Perez SM; Donegan JJ; Boley AM; Aguilar DD; Giuffrida A; Lodge DJ
    Schizophr Res; 2019 Apr; 206():263-270. PubMed ID: 30522798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia.
    Neves GA; Grace AA
    Neuropsychopharmacology; 2018 Jul; 43(8):1712-1720. PubMed ID: 29695783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia.
    Perez SM; Aguilar DD; Neary JL; Carless MA; Giuffrida A; Lodge DJ
    Neuropsychopharmacology; 2016 Jan; 41(2):477-86. PubMed ID: 26068729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.